Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02696603 · ClinicalTrials.gov registry record · NA

Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)

A NA study of Parkinson Disease and Movement Disorders, sponsored by Sage Bionetworks.

Active
Registry status
NA
Development phase
20,000
Enrollment target
1
Study location

NCT02696603 is a NA study of Parkinson Disease and Movement Disorders that is active but no longer recruiting, run by Sage Bionetworks. The registered enrollment target is 20,000 participants, above the 5,259-participant average among 297 other Parkinson Disease trials with a reported enrollment target (280% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02696603, a NA study of Parkinson Disease and Movement Disorders, is active but no longer recruiting, sponsored by Sage Bionetworks.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to understand variation in the symptoms of Parkinson disease. This study uses an iPhone app to record these symptoms through questionnaires and sensors.

Interventions

  • BEHAVIORAL Participant self-assessment surveys
  • BEHAVIORAL Phonation
  • BEHAVIORAL Gait and balance
  • BEHAVIORAL Memory
  • BEHAVIORAL Dexterity

Study Locations (1)

Washington

  • Sage Bionetworks - Seattle

Trial Details

FieldValue
Enrollment Target 20,000 participants
Start Date 2015-03
Est. Completion 2025-12-31
Phase NA

Sponsor

Sage Bionetworks

2 total trials

What the Registry Record Tells You About NCT02696603

The ClinicalTrials.gov registry entry for NCT02696603 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 5,259-participant average among 297 other Parkinson Disease trials with a reported enrollment target (280% higher). The listed sponsor is Sage Bionetworks, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 5 interventions - of which Participant self-assessment surveys is the first listed.

NCT02696603 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT02696603 about?

NCT02696603 is a clinical study titled "Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)". The purpose of this study is to understand variation in the symptoms of Parkinson disease. This study uses an iPhone app to record these symptoms through questionnaires and sensors.

What is the current status of trial NCT02696603?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20,000 participants. The study started on 2015-03. Estimated completion is 2025-12-31.

What conditions does trial NCT02696603 study?

This clinical trial studies the following conditions: Parkinson Disease, Movement Disorders, Central Nervous System Diseases, Brain Diseases, Neurodegenerative Diseases.

What interventions are being tested in trial NCT02696603?

The interventions under investigation include: Participant self-assessment surveys (BEHAVIORAL), Phonation (BEHAVIORAL), Gait and balance (BEHAVIORAL), Memory (BEHAVIORAL), Dexterity (BEHAVIORAL).

Who is sponsoring clinical trial NCT02696603?

This trial is sponsored by Sage Bionetworks, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02696603 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.